Fertility and Sterility
Volume 93, Issue 1 , Pages 62-67, 1 January 2010

Pain scoring in endometriosis: entry criteria and outcome measures for clinical trials. Report from the Art and Science of Endometriosis meeting

  • Katy Vincent, M.B.B.S.

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headley Way, Oxford, United Kingdom
    • Corresponding Author InformationReprint requests: Dr. Katy Vincent, Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headley Way, Oxford, OX3 9DU (FAX: 00-44-1865-222727).
    • ,
  • Stephen Kennedy, M.D.

      Affiliations

    • Nuffield Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Headley Way, Oxford, United Kingdom
    • ,
  • Pamela Stratton, M.D.

      Affiliations

    • Reproductive Biology and Medicine Branch, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland

Received 4 March 2008; received in revised form 17 September 2008; accepted 17 September 2008. published online 05 November 2008.

Standardized entry criteria and outcome measures for clinical trials in endometriosis-related pain would facilitate the comparison of trial results and the production of systematic reviews, improving evidence-based practice in this area. This report summarizes the recommendations from an international meeting for these criteria.

Key Words: Endometriosis, pain, quality of life, dysmenorrhea

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 K.V. has received funding from Pfizer. S.K. has received grant support from Pfizer and is on the advisory boards of TAP Pharmaceuticals, Takeda, and Bayer Schering-Plough. P.S. has nothing to disclose.

 This study was supported by the Intramural Program of the National Institute of Child Health and Human Development and unrestricted educational grants from Ferring, Neurocrine, Pfizer, Schering, Takeda, and TAP Pharmaceuticals.

PII: S0015-0282(08)04049-1

doi:10.1016/j.fertnstert.2008.09.056

Fertility and Sterility
Volume 93, Issue 1 , Pages 62-67, 1 January 2010

Article Tools